Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis

• Published in: Orphanet journal of rare diseases 2016-10, Vol.11 (1), p.141-141, Article 141
• Main Authors: Iudici, Michele, Quartier, Pierre, Terrier, Benjamin, Mouthon, Luc, Guillevin, Loïc, Puéchal, Xavier
• Format: Article
• Language: English
• Subjects: Adrenal Cortex Hormones - therapeutic use; Care and treatment; Cross-Sectional Studies; Cyclophosphamide - therapeutic use; Diagnosis; Disease Progression; Granulomatosis with polyangiitis; Granulomatosis with Polyangiitis - diagnosis; Granulomatosis with Polyangiitis - drug therapy; Granulomatosis with Polyangiitis - epidemiology; Granulomatosis with Polyangiitis - pathology; Humans; Medical research; Microscopic polyangiitis; Microscopic Polyangiitis - diagnosis; Microscopic Polyangiitis - drug therapy; Microscopic Polyangiitis - epidemiology; Microscopic Polyangiitis - pathology; Paediatrics; Rare diseases; Review; Risk factors
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/s13023-016-0523-y

The data from cohorts of childhood-onset granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) remain scarce and heterogeneous. We aimed to analyse the features at presentation, therapeutic approaches and the disease course of these rare diseases. Electronic searches of Medline and the Cochrane Central Register of Controlled trials database were conducted. We also checked the reference lists of the studies included and other systematic reviews, to identify additional reports. We included all cohorts, cross-sectional studies or registries reporting features at presentation or outcomes in patients with a diagnosis of childhood-onset GPA or MPA (age 90 % of children with GPA or MPA. Combined corticosteroids and cyclophosphamide was the most frequently used first remission-inducing treatment for GPA (76 % [95 % CI 69-82]) and MPA (62 % [95 % CI 20-96]). Relapses occurred more frequently in GPA (67-100 %) than in MPA (25-50 %). The leading causes of death were the disease itself, and infections. Childhood-onset MPA and GPA remain severe diseases with frequent relapses and a high cumulative morbidity. Survival and disease-free survival need to be improved.